Future Oncology, Volume 16, Issue 15 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 16, Issue 15 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Immunotherapy in Elderly Patients: Should We Stay or Should We Go?
Vincenzo Di Nunno, Enrico Franceschi & Alba A Brandes
Pages: 973-974
Published online: 14 Apr 2020
CitationforImmunotherapy in Elderly Patients: Should We Stay or Should We Go? | Full Text | References | PDF (1.2 MB) | EPUB
  • 126 Views
  • 3 CrossRef citations
  • 0Altmetric

Clinical Trial Protocol

Review Article
IMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation
Stephen P Hack, Jessica Spahn, Minshan Chen, Ann-Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow & Shukui Qin
Pages: 975-989
Published online: 30 Apr 2020
AbstractforIMbrave 050: A Phase III Trial of Atezolizumab Plus Bevacizumab in High-Risk Hepatocellular Carcinoma after Curative Resection or Ablation | Full Text | References | PDF (5.1 MB) | EPUB | Supplemental
Infographic: A PDF version of this infographic is available as supplemental material.
  • 33667 Views
  • 127 CrossRef citations
  • 0Altmetric
Open Access
Review Article
ENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1
Grzegorz S Nowakowski, Jun Zhu, Qingyuan Zhang, Joshua Brody, Xiuhua Sun, Joseph Maly, Yuqin Song, Syed Rizvi, Yongping Song, Frederick Lansigan, Hongmei Jing, Junning Cao, Jennifer K Lue, Wen Luo, Lei Zhang, Ling Li, Isabel Han, Joan Sun, Manoj Jivani, Young Liu, Thomas Heineman & Stephen D Smith
Pages: 991-999
Published online: 06 Apr 2020
AbstractforENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1 | Full Text | References | PDF (1.3 MB) | EPUB
  • 4584 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access

Short Communication

Brief Report
Real-World Use and Acceptance of Rituximab Biosimilars in Non-Hodgkin Lymphoma in an Oncologist Network in Germany
Burkhard Otremba, Jens Borchardt, Andra Kuske, Maike Hollnagel-Schmitz & Florian O Losch
Pages: 1001-1012
Published online: 14 Apr 2020
AbstractforReal-World Use and Acceptance of Rituximab Biosimilars in Non-Hodgkin Lymphoma in an Oncologist Network in Germany | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 15832 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Real-World Treatment Patterns in Patients with Advanced (Stage III–IV) Ovarian Cancer in the USA and Europe
Jennifer P Hall, Jane Chang, Rebecca Moon, Olivia Higson, Katherine Byrne, Jim P Doherty & Joseph C Cappelleri
Pages: 1013-1030
Published online: 24 Apr 2020
AbstractforReal-World Treatment Patterns in Patients with Advanced (Stage III–IV) Ovarian Cancer in the USA and Europe | Full Text | References | PDF (1.5 MB) | EPUB
  • 503 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Real-World Treatment Duration in ALK-Positive Non-Small-Cell Lung Cancer Patients Receiving Brigatinib Through the Early Access Program
Huamao M Lin, Xiaoyun Pan, Peijie Hou, Susan Allen, Pia Baumann & Maximilian J Hochmair
Pages: 1031-1041
Published online: 27 Apr 2020
AbstractforReal-World Treatment Duration in ALK-Positive Non-Small-Cell Lung Cancer Patients Receiving Brigatinib Through the Early Access Program | Full Text | References | PDF (1.8 MB) | EPUB
  • 5738 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Whole Lung Irradiation for Completely Responding Pulmonary Metastases in Pediatric Ewing Sarcoma
Hagar Elghazawy, Azza Nasr, Iman Zaky, Manal Zamzam, Ahmed Elgammal, Nesma Farid & Mohamed S Zaghloul
Pages: 1043-1051
Published online: 06 Apr 2020
AbstractforWhole Lung Irradiation for Completely Responding Pulmonary Metastases in Pediatric Ewing Sarcoma | Full Text | References | PDF (1.6 MB) | EPUB
  • 321 Views
  • 7 CrossRef citations
  • 0Altmetric

Review

Review Article
Predictive Markers of Immune Response in Glioblastoma: Hopes and Facts
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Stefania Bartolini & Alba Ariela Brandes
Pages: 1053-1063
Published online: 09 Apr 2020
AbstractforPredictive Markers of Immune Response in Glioblastoma: Hopes and Facts | Full Text | References | PDF (3.4 MB) | EPUB
  • 245 Views
  • 13 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
Jingchuan Zhang et al.
Rapid Communication | Published online: 9 Aug 2024
Open Access
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Isabel Blancas et al.
Rapid Communication | Published online: 8 Aug 2024
Open Access
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding et al.
Plain Language Summary of Publication | Published online: 8 Aug 2024
Open Access
Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Jesús San-Miguel et al.
Plain Language Summary of Publication | Published online: 7 Aug 2024
Open Access
View all latest articles